Saeed uz Zafar M, Mellinger R C, Fine G, Szabo M, Frohman L A
J Clin Endocrinol Metab. 1979 Jan;48(1):66-71. doi: 10.1210/jcem-48-1-66.
A patient with acromegaly, pituitary enlargement, and elevated plasma GH levels also had a bronchial carcinoid tumor. Signs and symptoms of active acromegaly along with elevated GH levels persisted for 11 yr after hypophysectomy and pituitary stalk section. Resection of the bronchial carcinoid reduced plasma GH to barely detectable levels. Extracts of the frozen carcinoid tumor were devoid of significant GH, but when added to isolated pituitary cells of estrogen-primed male rats in 4-day primary culture exhibited specific GH-releasing activity in vitro. These findings strongly suggest that the patient's acromegaly resulted from continual stimulation of pituitary somatotrophs by a GH-releasing factor secreted by the bronchial carcinoid.
一名患有肢端肥大症、垂体肿大且血浆生长激素(GH)水平升高的患者还患有支气管类癌肿瘤。在垂体切除术和垂体柄切断术后,活跃肢端肥大症的体征和症状以及升高的GH水平持续了11年。支气管类癌的切除使血浆GH降至几乎检测不到的水平。冷冻类癌肿瘤的提取物中没有明显的GH,但当添加到雌激素预处理的雄性大鼠的离体垂体细胞中进行4天的原代培养时,在体外表现出特定的GH释放活性。这些发现强烈表明,该患者的肢端肥大症是由支气管类癌分泌的GH释放因子持续刺激垂体生长激素细胞所致。